Furthermore, NASH‐driven HCC mice models by feeding wildtype mice with high‐fat/high‐cholesterol (HFHC) diet and low dose carbon tetrachloride (CCl4) treatment is established; and identified that hepatic FGF9 is increased; with severe fibrosis. The gene discussed is FGF9; the disease is metabolic dysfunction-associated steatohepatitis.